Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

437 recalls, newest first

Class I · High risk

Goodness Gurus

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1461-2020
Class I · High risk

Goodness Gurus

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1460-2020
Class I · High risk

BC Hemp Co.

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1459-2020
Class I · High risk

BC Hemp Co.

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1458-2020
Class I · High risk

BC Hemp Co.

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1457-2020
Class I · High risk

A Clean Choice CBD

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1456-2020
Class I · High risk

A Clean Choice CBD

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1455-2020
Class I · High risk

A Clean Choice CBD

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1454-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. D-0185-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 63868-480-24 D-0184-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 0363-0131-30 D-0183-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 11673-849-40 D-0179-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. D-0178-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 71713-203-02 D-0177-2020

Recalls by year